PMDA completes inspection of SMS Pharmaceuticals’ manufacturing facility at Telangana

23 Aug 2017 Evaluate

SMS Pharmaceuticals’ manufacturing facility-Unit II located at Bachupally, Ranga Reddy District, Hyderabad, Telangana, India was successfully inspected by Pharmaceuticals and Medical Devices Agency (PMDA), Japan Authorities. The inspection was carried out between July 25, 2017 to July 27, 2017.

SMS Pharmaceuticals is a global player in API manufacturing having strong research and manufacturing team supported by state of art facilities. They are the single largest producer of anti-ulcer products.

SMS Pharmaceuticals Share Price

317.40 -6.65 (-2.05%)
16-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.80
Dr. Reddys Lab 1279.00
Cipla 1500.00
Zydus Lifesciences 913.90
Lupin 2089.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×